Logo

American Heart Association

  193
  0


Final ID: MP38

The Implications of COVID-19 Pandemic for The Black-White Diabetes Mortality Gap: Has The Disparity’s Dynamic Changed?

Abstract Body: BACKGROUND: Previous studies have investigated racial disparities in diabetes mellitus, including the existence of diabetes mortality gap between African Americans and whites. However, it remains unknown whether the coronavirus SARS-CoV-2 (COVID-19) pandemic changed the magnitude of earlier documented Black-White gap in diabetes mortality. STUDY OBJECTIVE: To investigate the dynamic change in the magnitude of the Black-White diabetes mortality gap in relation to COVID-19 pandemic. METHODS: Diabetes mortality rates in relation to race, adjusting for major covariates, were analyzed using the Centers for Disease Control and Prevention (CDC) Wide-Ranging Online Data for Epidemiologic Research (WONDER) database on underlying causes of death in the United States. Diabetes mortality was analyzed for the three years preceding the pandemic (2017-2019; defined as pre-COVID era diabetes mortality) and the first three years of the pandemic (March 2020 to February 2023; defined as COVID-era diabetes mortality). Diabetes deaths were identified in the CDC WONDER database using the ICD-10 codes E10-E11. To adjust for multiple covariates, general linear modeling (GLM) analysis was conducted (SAS, ver. 9.4). RESULTS: Both African Americans and whites experienced an increase in diabetes mortality rates from the pre-COVID-era to COVID-era period: from 11.0/100,000 to 15.1/100,000 (crude mortality rates) and from 12.4/100,000 to 15.9/100,000 age-adjusted mortality rates) in African Americans; from 10.9/100,000 to 14.1/100,000 (crude mortality rates) and from 8.3/100,000 to 10.3/100,000 age-adjusted mortality rates) in whites. However, when comparing the magnitude of the change in diabetes mortality rates between the pre-COVID and COVID-era periods, the multivariate-adjusted diabetes mortality rate increase in African Americans was 4.26/100,000 greater than in whites (p=0.028). CONCLUSIONS: COVID-19 pandemic had a statistically significant impact on the magnitude of racial gap in diabetes mortality. Further research investigating the underlying mechanisms of these findings is warranted.
  • Sergeev, Alexander  ( OHIO UNIVERSITY , Athens , Ohio , United States )
  • Author Disclosures:
    Alexander Sergeev: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

MP07. Diabetes

Friday, 03/07/2025 , 05:00PM - 07:00PM

Moderated Poster Session

More abstracts on this topic:
Achieving Guidelines within a 24-Hour Movement Paradigm and Risk of Cardiovascular Disease and All-Cause Mortality in United States Adults

Boudreaux Benjamin, Xu Chang, Dooley Erin, Hornikel Bjoern, Munson Alexandra, Shechter Ari, Palta Priya, Gabriel Kelley, Diaz Keith

An Epigenetic Drug, GSK126 Mitigates Endothelial to Mesenchymal Transition Attenuating Atherosclerosis in Diabetes

Aziz Misbah, Jandeleitdahm Karin, Khan Abdul Waheed

You have to be authorized to contact abstract author. Please, Login
Not Available